Endologix, Inc.  

(Public, NASDAQ:ELGX)   Watch this stock  
Find more results for endologix
-0.12 (-1.82%)
Feb 17 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 6.73 - 6.96
52 week 4.78 - 14.49
Open 6.90
Vol / Avg. 2.51M/1.83M
Mkt cap 548.84M
P/E     -
Div/yield     -
EPS -1.85
Shares 82.69M
Beta 0.87
Inst. own 108%
Feb 20, 2017
Q4 2016 Endologix Inc Earnings Release (Estimated)
Jan 11, 2017
Endologix Inc at JPMorgan Healthcare Conference
Dec 30, 2016
Endologix Inc AFX Shipment Update Conference Call
Dec 27, 2016
Endologix Inc AFX Update Conference Call
Dec 13, 2016
Endologix Inc at Guggenheim Boston Healthcare Conference
Nov 30, 2016
Endologix Inc at Piper Jaffray Healthcare Conference
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '16) 2015
Net profit margin -29.25% -32.83%
Operating margin -21.55% -34.51%
EBITD margin - -27.30%
Return on average assets -15.91% -17.41%
Return on average equity -44.02% -44.34%
Employees 619 -
CDP Score - -


2 Musick
IRVINE, CA 92618-1631
United States - Map
+1-949-5957200 (Phone)
+1-949-6999622 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Endologix, Inc. is engaged in developing, manufacturing, marketing and selling medical devices for the treatment of aortic disorders. The Company's products are intended for the treatment of abdominal aortic aneurysms (AAA). The AAA products are built on one of two platforms, including traditional minimally invasive endovascular repair (EVAR) or endovascular sealing (EVAS), its solution for sealing the aneurysm sac while maintaining blood flow through two blood flow lumens. The EVAR products include the Endologix AFX Endovascular AAA System (AFX), the VELA Proximal Endograft (VELA) and the Endologix Powerlink with Intuitrak Delivery System (Intuitrak). The EVAS product is the Nellix EndoVascular Aneurysm Sealing System (Nellix EVAS System). Its EVAS product is the Nellix EndoVascular Aneurysm Sealing System (Nellix EVAS System). It offers accessories to facilitate the optimal delivery of its EVAR products, including compatible guidewires, snares, and catheter introducer sheaths.

Officers and directors

Daniel T. Lemaitre Chairman of the Board
Age: 62
Bio & Compensation  - Reuters
Robert D. Mitchell President
Age: 54
Bio & Compensation  - Reuters
John D. McDermott Chief Executive Officer, Director
Age: 56
Bio & Compensation  - Reuters
Vaseem Mahboob Chief Financial Officer, Corporate Secretary
Age: 47
Bio & Compensation  - Reuters
Michael V. Chobotov Ph.D. Chief Technology Officer
Age: 55
Bio & Compensation  - Reuters
David M. Jennings Vice President - Human Resources
Age: 61
Bio & Compensation  - Reuters
Amanda L. DePalma Vice President - Global Marketing
Age: 44
Bio & Compensation  - Reuters
Laura Nagel Vice President - Global Quality
Bio & Compensation  - Reuters
Shari L. O'Quinn Vice President - Regulatory and Quality Affairs
Age: 43
Bio & Compensation  - Reuters
James E. Machek Vice President - Research and Development, Manufacturing, Irvine
Age: 59
Bio & Compensation  - Reuters